Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Price / Book

Acadia Pharmaceutica Price / Book Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Price / Book from 2010 to 2020. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Acadia Pharmaceutica Price / Book for the quarter ending September 09, 2020 was 9.17 a -7.02% decrease of -0.64 year over year
  • Acadia Pharmaceutica Price / Book for the last 12 months ending September 09, 2020 was 9.17 a -7.02% decrease of -0.64 year over year
  • Acadia Pharmaceutica Annual Price / Book for 2020 was 9.17 a -4.77% decrease of -0.44 from 2019
  • Acadia Pharmaceutica Annual Price / Book for 2020 was 9.60 a -1.29% decrease of -0.12 from 2019
  • Acadia Pharmaceutica Annual Price / Book for 2020 was 9.73 a -0.85% decrease of -0.08 from 2019
Other Valuation Metrics:
  • Acadia Pharmaceutica Market Cap for the quarter ending March 03, 2018 was $2,802m a -21.48% decrease of -602m year over year
  • Acadia Pharmaceutica Enterprise Value for the quarter ending March 03, 2018 was $2,461m a -19.25% decrease of -474m year over year
View Chart On Koyfin

Quarterly ACAD Price / Book Data

09/20209.17
09/20209.60
09/20209.73
09/20209.81
09/202010.07
09/20209.68
09/20209.31
09/20209.21
09/20209.17
09/20208.69

Annual ACAD Price / Book Data

20209.17
20209.60
20209.73
20209.81
202010.07
20209.68
20209.31
20209.21
20209.17
20208.69